Please provide your email address to receive an email when new articles are posted on . The device significantly improved quality of life and symptoms among women with urgency urinary incontinence ...

Medtech companies are increasingly investing in neuromodulation to treat UUI, which is estimated to impact 20% of adults worldwide.

The FDA has cleared InTone, a medical device for treating female urinary incontinence. InTone is the first medical device that combines mild micro-current stimulation (similar to a transcutaneous ...

Credit: Watkins-Conti. Yōni.Fit is a self-administered, intravaginal insert that manages urinary incontinence without interfering with voluntary urination. The prescription device can be used during a ...

Key findings included 94% of test-phase responders experienced at least a 50% decrease in episodes of UUI.

The one-year data shows that 80% of people benefited from the device. It's implanted in the ankle and stimulates a nerve.

The majority of adult women in the US suffer urinary incontinence (UI), with the most common form of UI being Stress Urinary Incontinence (SUI), which is often caused by weak pelvic floor muscles. SUI ...

Zynex has announced it received FDA clearance for a new device used primarily for treating female urinary incontinence, according to a news release. The InWave medical device will be manufactured, ...

Company is Poised to Participate in $4B U.S. Adult Urinary Incontinence Market EDMOND, Okla., May 17, 2024 /PRNewswire/ -- Watkins-Conti Products, Inc. ("Watkins-Conti"), a company that develops ...

Relief Srl raised more than €1 million (US$1.08 million) in financing for Urorelief, its endourethral medical device which treats stress urinary incontinence. The Italian startup will use the funds to ...